ACCC's Technical Advisory Council

McKesson Specialty Care Solutions
401 Mason Road
La Vergne, TN 37086
Phone: 800.482.6700

Company Information
McKesson provides comprehensive services, including technology, pharmaceuticals, supportive care products, and medical and surgical supplies to physicians practicing in the community-treatment setting. The company is committed to providing its customers with the support and resources necessary to ensure their success. These include distribution resources, technology and practice management solutions, clinical services, educational opportunities, and more:

• Best-in-class pricing: McKesson provides best-in-class pharmaceutical pricing, distribution services, and customer service and is committed to being the low-cost provider of drugs.
• Technology resources and practice management: Lynx® is McKesson's oncology-specific, web-based technology platform that helps physician practices increase revenue, get paid faster, and succeed with quality care initiatives.
• Clinical services: McKesson's knowledgeable clinical team is led by Kim Bergstrom, a recognized leader in development and implementation of clinical guidelines and programs within community oncology.
• McKesson specialty services: McKesson’s specialty pharmacy provides patients convenient home delivery of oral anti-cancer medications. Practices will be able to track patients’ compliance to their oral medication regimens through monthly tracking reports. McKesson Specialty Pharmacy also has a benefits investigation team that eases the administrative burden of dealing with pre-authorizations and insurance claims.
• Sales and marketing resources: McKesson has a robust sales and marketing staff dedicated to the community oncology market.

 

Onmark
Onmark, a McKesson Specialty Care Solutions Company, is the leading national group purchasing organization for community-based practices. Onmark provides the premier contract portfolio plus innovative business and clinical solutions to help members operate more efficiently and deliver cost-effective, high-quality patient care.

Through strategic relationships with McKesson, pharmaceutical companies, and industry experts, Onmark helps its members save money, increase efficiency, and stay informed by offering a wide variety of services, including:

• A competitive contract portfolio that offers significant savings on the majority of the most widely-used chemotherapy, biologic, and supportive care agents, both brand and generic.
• Educational programs covering clinical, practice management, and legislative topics.
• The Regimen Profiler™, a web-based tool that helps practices and patients understand financial and clinical information for many disease treatment regimens.
• The Annual Office-Based Oncology Business Benchmarking Survey, which captures key operational and financial benchmarks from community oncology practices nationwide. Respondents receive a copy of the survey results so that they may compare their own metrics to national standards and evaluate performance over time. Over 160 practices in 35 states participated in the 2007 survey.
• A clinical trial network. In January 2007, Onmark partnered with Quintiles to create a national clinical trial network of Onmark members. Through this partnership, Onmark members have the opportunity to participate in Phase II and Phase III clinical trials of investigational cancer treatments.
• Online clinical materials that are written the way chemotherapy is administered—by regimen. Treatment Information Sheets help patients understand the treatment they will receive and Clinical Outcomes Tables help staff evaluate different treatment options.
• The Clinical Reporting Initiative (CRI) Program. Onmark members using the Lynx MobileTM module can participate in the CRI Program. Participants earn money by providing recent treatment decision insights from their practice.
• he Preparation Techniques for Hazardous Drugs (PTHD) Program. This program is a convenient way for new or experienced oncology nursing staff to review the fundamentals of handling and preparing hazardous drugs including chemotherapy. The program is approved for a total of 5.0 contact hours by the Oncology Nursing Society (ONS).

To join Onmark, download an enrollment application on www.onmarkservices.com or call 866.686.8340. There are no fees or purchase requirements, and you will receive immediate access to all member benefits.

Prometheus
9410 Carroll Park Drive
San Diego, CA 92121
Phone: 877.378.4919
Fax: 877.816.4019

Company Information
Prometheus Laboratories Inc. is a specialty pharmaceutical and diagnostic company committed to developing and commercializing novel pharmaceutical and diagnostic products to help physicians individualize patient care. Recently, Prometheus acquired the exclusive sales and marketing rights in the U.S. to three molecular diagnostic oncology tests recently introduced in the market by Rosetta Genomics, LTD. These microRNA-based tests may be used by Medical Oncologists to help determine optimum treatments and as an aid in diagnosing certain types of cancer. These new tests are now commercially available and we have hired a specialty oncology sales force to market these tests listed below.

ProOnc TumorSource^{Dx TM}
Helps identify the primary origin of metastatic tumors. This test identifies 25 different tumor types.

Clinical Importance: In the U.S., thousands of patients are diagnosed each year with a cancer that has already metastasized without identifying its primary site. As metastases need to be treated according to the primary origin, accurate identification of the metastases’ primary origin can be critical for determining appropriate treatment. Current diagnostic methods include a wide range of costly and time consuming histopathology analyses of the biopsy, imaging methods such as chest X-ray, CT and PET scans and endoscopies.

ProOnc Squamous^{Dx TM}
Helps differentiate Squamous from Non-Squamous Non-Small-Cell-Lung-Cancer.

Clinical Importance: When administered targeted therapy, whether currently available or under development, patients with squamous cell carcinoma of the lung have demonstrated varying response patterns ranging from a high incidence of severe or fatal hemoptysis (internal bleeding in the lungs) to a lack of response to treatment.

ProOnc Mesothelioma^{Dx TM}
Helps distinguish malignant pleural Mesothelioma from other carcinomas in the lung and pleura.

US Oncology
10101 Woodloch Forest Dr.
The Woodlands, TX 77380
Phone: 800-381-2637

Company Information

Supporting cancer care delivery since 1999

US Oncology touches nearly every aspect of cancer care from research, specialty pharmacy and drug distribution to billing and reimbursement, electronic health records (EHR), continuing education and the use of evidence-based medicine pathways. Headquartered in the Houston, Texas area, US Oncology works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers to identify and deliver innovative services that enhance patient access to advanced cancer care.

Solutions for Physician Practices
Helping community practices thrive.

Physicians and community practices can achieve their goals and improve the patient experience through our comprehensive and targeted services. The use of evidence-based pathways, disease management and advance care planning offers patients and payers consistent treatment with more predictable outcomes and costs. Physician practices can join with US Oncology in two ways: by choosing our broadest offering, called the Comprehensive Strategic Alliance, or by choosing from a wide menu of targeted offerings.

With the Comprehensive Strategic Alliance, physician practices gain access to a full portfolio of clinical and business services. They also join an industry-leading network that serves as a resource to improve patient care through sharing best practices, consulting experts in specific areas, weighing in on public policy issues, and contributing to every aspect of cancer care and its delivery.

Our targeted services leverage our years of insight to address specific practice needs. From drug purchasing, drug management, and clinical research, to pay-for-performance opportunities, this menu of offerings helps practices of any size improve their performance and enhance their delivery of high-quality care.

Services for physician practices include:

• Comprehensive Strategic Alliance – Full-service offering for physicians and community-based practices
• iKnowMed – Oncology-specific electronic health record system
• Innovent Oncology – Integrated, collaborative solution to key cost drivers for patients and payers
• Level I Pathways – Evidence-based medicine
• Oncology Pharmaceutical Services– VAWD-certified drug distribution and management
• Oncology Today – Medical education services for practitioners
• OncologyRx Care Advantage – Oral oncology specialty pharmacy and patient compliance support
• US Oncology Research – Research network specializing in Phase I - IV oncology clinical trials

To learn more about how US Oncology works with patients, manufacturers and payers, visit www.usoncology.com.